Critics of co-pay coupons allege these payments allow branded manufacturers to circumvent incentives to encourage the use of lower-cost alternatives. With increased use of these coupons, as well as several high-profile cases in the courts, it is timely to explore the economic effects of co-pay coupons and consider a framework for assessing their impact. Click the link below to read more.
Roundtable: Transitioning Medical Affairs to strategically co-lead clinical development and commercialization efforts
In May 2023, CRA’s Life Sciences Practice held a roundtable discussion with Medical Affairs leaders in Lisbon on best practices in transitioning from a...